ChromaDex

+$0.15 (+8.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ChromaDex and other ETFs, options, and stocks.

About CDXC

Chromadex Corp. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+).

CEO
Robert N. Fried
Employees
115
Headquarters
Los Angeles, California
Founded
1999

CDXC Key Statistics

Market cap
130.52M
Price-Earnings ratio
—
Dividend yield
—
Average volume
527.67K
High today
$2.18
Low today
$1.84
Open price
$1.88
Volume
1.64M
52 Week high
$10.78
52 Week low
$1.51

CDXC News

Benzinga13h

ChromaDex Establishes Joint Venture For Tru Niagen Distribution In China

In this article: ChromaDex Corp (NASDAQ: CDXC) has agreed to establish a joint venture through its wholly-owned subsidiary ChromaDex Asia Limited. ChromaDex A
Simply Wall StMay 17

How Much Of ChromaDex Corporation Do Insiders Own?

A look at the shareholders of ChromaDex Corporation (NASDAQ:CDXC) can tell us which group is most powerful. Insiders often own a large chunk of younger, smaller

CDXC Earnings

-$0.13
-$0.11
-$0.09
-$0.07
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.09 per share
Actual
-$0.11 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure